Coherus Biosciences | CHRS - الربح الإجمالي على المبيعات





الربح الإجمالي على المبيعات تغيير تاريخ
AbbVie USD 12.54B 474M 2026-03
Acadia Pharmaceuticals USD 243.27M 14.49M 2026-03
Akebia Therapeutics USD 47.28M 1.7M 2025-12
ALKERMES USD 331.33M 7M 2026-03
Alnylam Pharmaceuticals USD 992.69M 167.68M 2026-06
Amarin USD 23.17M 961K 2025-12
Amgen USD 6.89B 415M 2025-12
Baxter International USD 1.14B 251M 2026-06
Biogen USD 2.12B 307M 2026-06
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Coherus Biosciences USD 8.7M 853K 2025-12
Eli Lilly USD 15.92B 1.33B 2025-12
Fujifilm JPY 376.67B 29.16B 2026-03
Gilead Sciences USD 5.52B 791M 2026-03
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
Merck USD 10.85B 2.57B 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
Pacira USD 126.64M 15.61M 2026-03
Perrigo USD 325.5M 36.7M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
PTC Therapeutics USD 232.94M 84.56M 2026-03
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Sarepta Therapeutics USD 621.34M 577.79M 2026-03
Teva Pharmaceutical Industries USD 2.15B 45M 2026-06
Vertex Pharmaceuticals USD 2.6B 121.7M 2026-03
Xencor USD 21M 22.61M 2025-09
Zoetis USD 1.62B 20M 2026-03